Sharpen your skills in adverse event management for anti-CD38 monoclonal antibody-based treatment combinations in early relapsed/refractory multiple myeloma (R/R MM). In the final case of this 3-part case challenge series, you’ll be able to test your skills in a real-world clinical case scenario focused on monitoring, managing, and patient counseling for treatment-related toxicity.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/best-practices-monitoring-managing-adverse-events-associated-early-r-r-mm
- Start Date: 2024-10-30 05:00:00
- End Date: 2024-10-30 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Sanofi S.A. - Amount: 19875.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology
Subscribe
Login
0 Comments
Oldest